J-Pharma

520A.TTSE GROWTHPharmaceutical

In English · 4

Thu, May 14 · JST1 filing

16:50MATERIALJ-Pharma · Event with a material impact on financial position

Wed, Apr 1 · JST1 filing

11:365% STAKEJ-Pharma · JIC Venture Growth Investments Co., Ltd. · 11.34%new 11.34%

Tue, Mar 31 · JST1 filing

15:325% STAKEJ-Pharma · Eight Roads Ventures Japan II LP · 10.88%new 10.88%

Thu, Mar 26 · JST1 filing

11:245% STAKEJ-Pharma · Newton Biocapital I, pricaf privee de droit belge · 6.87%new 6.87%

All EDINET filings · 13

All Financial 1 5% 3 Material 4 Other 5

Filed	Document	Filer	Source
2026-07-01	Material event report	J-Pharma Co., Ltd.	S100YO6J
2026-06-24	CEO/CFO certification	J-Pharma Co., Ltd.	S100YJW9
2026-06-24	Internal control report	J-Pharma Co., Ltd.	S100YJW1
2026-06-24	Annual report	J-Pharma Co., Ltd.	S100YJUW
2026-05-14	Material event report	J-Pharma Co., Ltd.	S100Y45M
2026-04-08	Material event report	J-Pharma Co., Ltd.	S100XXSU
2026-04-01	Large shareholding report	Jeiaishibenchagurosuinbesutomentsu	S100XT03
2026-03-31	Large shareholding report	Eight Roads Ventures Japan II LP	S100XVO5
2026-03-26	Large shareholding report	Nutonbaiokapitaruwanpurikafupurivedoudorowaberuju	S100XTZW
2026-03-25	Material event report	J-Pharma Co., Ltd.	S100XU1C
2026-03-13	Amended securities registrationRelated to S100XMFB	J-Pharma Co., Ltd.	S100XQVL
2026-03-05	Amended securities registrationRelated to S100XMFB	J-Pharma Co., Ltd.	S100XP5Y
2026-02-19	Securities registration	J-Pharma Co., Ltd.	S100XMFB

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.